Article
Author(s):
NanoMed Pharmaceuticals, Inc. (Kalamazoo, MI, www.nanomedpharm.com), has appointed Harry C. Ledebur, Jr., PhD, as the company's vice president of research and development and chief scientific officer.
NanoMed Pharmaceuticals, Inc. (Kalamazoo, MI, www.nanomedpharm.com), has appointed Harry C. Ledebur, Jr., PhD, as the company's vice president of research and development and chief scientific officer. Before joining NanoMed, Ledebur was VP of operations and scientific affairs for Chromos Molecular Systems, Inc.
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.